Clinical trial
Study of Occipital Nerve Stimulation for Drug Refractory Migraine
NCT00747812 · Boston Scientific Corporation, Industry · Terminated
Key facts
| NCT number | NCT00747812 |
|---|---|
| Title | Study of Occipital Nerve Stimulation for Drug Refractory Migraine |
| Official title | A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Occipital Nerve Stimulation for Drug Refractory Migraine |
| Acronym | PRISM UK |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Device |
| Interventions | Precision |
| Enrollment | 11 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | May 1, 2012 |
| First posted | Sep 5, 2008 |
| Last update posted | Nov 27, 2020 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: